Pregistry

This study follows 2,000 pregnant women who received monoclonal antibodies or antiviral drugs for COVID-19 to see how these treatments affect pregnancy, newborns, and infant development up to 12 months old. Researchers compare their outcomes with those of pregnant women who did n…

This study follows 6,000 pregnant women—some vaccinated against COVID-19, some not—to compare pregnancy outcomes, newborn health, and infant development up to 12 months. Researchers will track risks like miscarriage, birth defects, and growth. No vaccine or treatment is given; it…